- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Saxagliptin/Metformin XR FDC
Total 367 results
-
Seoul National University Bundang HospitalCompletedType 2 DiabetesKorea, Republic of
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Non-Insulin-Dependent | Type 2 Diabetes Mellitus, Non Insulin Dependent
-
Merck Sharp & Dohme LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
Joslin Diabetes CenterEnrolling by invitationType 1 Diabetes | Monogenic DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Turkey, Canada, Finland, France, Hungary, Korea, Republic of
-
Merck Sharp & Dohme LLCTerminatedDiabetes Mellitus, Type 2
-
Pauls Stradins Clinical University HospitalCompletedCoronary Artery Disease | Atherosclerosis | Prediabetic StateLatvia
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Sheikh Zayed Federal Postgraduate Medical InstituteCompletedDiabetes Mellitus | Randomized Controlled TrialPakistan
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Dawn Smiley MDCompletedHyperglycemia | Ketosis Prone Diabetes | Diabetes KetoacidosisUnited States
-
Sun Yat-sen UniversityUnknownDiabetes Mellitus, Type 2
-
Profil Institut für Stoffwechselforschung GmbHSanofiCompletedType 2 DiabetesGermany
-
Emory UniversityMerck Sharp & Dohme LLC; University of Michigan; Temple University; Ohio UniversityCompleted
-
Dexa Medica GroupCompletedMetformin XR BE Study in Healthy Volunteers With Single and Multiple DoseIndonesia
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Woman'sMerck Sharp & Dohme LLCCompletedDisorder of Glucose RegulationUnited States
-
University of DiyalaCompleted
-
Norwegian University of Science and TechnologyCompleted
-
Sun Yat-sen UniversityCompletedNon-alcoholic Fatty Liver DiseaseChina
-
BayerCompleted
-
Nick Giannoukakis, PhDUniversity of South Florida; AstraZeneca; University of Pittsburgh; National Institutes...CompletedType 2 Diabetes Mellitus | Insulin ResistanceUnited States
-
Galenicum HealthCompletedType 2 Diabetes | BioequivalenceCanada
-
Galenicum HealthCompletedDiabetes Mellitus, Type 2 | BioequivalenceCanada
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
University of CincinnatiCompletedHead and Neck CancerUnited States
-
AstraZenecaCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Merck Sharp & Dohme LLCPfizerCompletedType 2 Diabetes Mellitus
-
BC World Pharm Co. Ltd.CompletedHealthyKorea, Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
-
Galenicum HealthCompletedDiabetes Mellitus, Type 2 | BioequivalenceMexico
-
Galenicum HealthCompletedDiabetes Mellitus, Type 2 | BioequivalenceMexico
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)Germany
-
University of BasrahRecruiting
-
AstraZenecaCompletedDiabetesTaiwan, United States, Russian Federation, India
-
HK inno.N CorporationCompletedFood Effect Study of CJ-30056 20mg/500mgKorea, Republic of
-
Galenicum HealthCompleted
-
Galenicum HealthCompletedDiabetes Mellitus, Type 2 | BioequivalenceMexico
-
Population Health Research InstituteMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusCanada
-
Beni-Suef UniversityMinia UniversityCompletedDiabetes Mellitus, Type 2Egypt